Brief report · 30 Nov 2025
ArticlePublished 30 Mar 2024
Targeting Epigenetic Modifications in Cancer Therapy Challenges and Opportunities
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Epigenetic modifications play a critical role in the development and progression of cancer by regulating gene expression patterns, chromatin structure, and cellular phenotypes. Targeting epigenetic abnormalities has emerged as a promising therapeutic strategy for cancer treatment, offering opportunities to reverse aberrant gene silencing, restore tumor suppressor function, and inhibit oncogenic signaling pathways. In this review, we discuss the challenges and opportunities of targeting epigenetic modifications in cancer therapy. We explore the mechanisms of epigenetic dysregulation in cancer, the therapeutic agents targeting epigenetic enzymes and readers, the clinical applications of epigenetic therapies, and the challenges associated with drug resistance, toxicity, and patient selection. Despite challenges, epigenetic therapies hold promise for improving cancer treatment outcomes and overcoming therapeutic resistance through personalized and precision medicine approaches.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Biomedical and Pharmaceutical Sciences.
Article · 29 Nov 2025
Mechanisms of Cancer Drug Resistance and Overcoming Them
Article · 29 Nov 2025
Tumor Microenvironment: Key to Cancer Progression and Therapy
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Biomedical and Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mara Sinclair”
